Ad
related to: cervicogenic headache adalah obat berapa cm 5 8 shackle
Search results
Results From The WOW.Com Content Network
Cervicogenic headache is a type of headache characterized by chronic hemicranial pain referred to the head from either the cervical spine or soft tissues within the neck. [1] [2] The main symptoms of cervicogenic headaches include pain originating in the neck that can travel to the head or face, headaches that get worse with neck movement, and limited ability to move the neck.
Barré–Liéou syndrome is regarded by many current medical researchers as synonymous with cervicogenic headache. Thus, the original works of Barré and Liéou were foundational in identifying a crucial feature that distinguishes cervicogenic headache from other headache syndromes—the concept that the pain originates from a structural ...
After migraine, the most common type of vascular headache is the "toxic" headache produced by fever. Other kinds of vascular headaches include cluster headaches, which are very severe recurrent short lasting headaches, often located through or around either eye and often wake the patients up at the same time every night. Unlike migraines, these ...
The International Classification of Headache Disorders (ICHD) is a detailed hierarchical classification of all headache-related disorders published by the International Headache Society. [1] It is considered the official classification of headaches by the World Health Organization , and, in 1992, was incorporated into the 10th edition of their ...
It is estimated that chronic headaches affect "4% to 5% of the general population". [2] Chronic headaches consist of different sub-groups, primarily categorized as chronic tension-type headaches and chronic migraine headaches. [2] The treatments for chronic headache are vast and varied.
Dihydroergotamine (DHE), sold under the brand names D.H.E. 45 and Migranal among others, is an ergot alkaloid used to treat migraines. [7] It is a derivative of ergotamine.It is administered as a nasal spray or injection and has an efficacy similar to that of sumatriptan.
This page was last edited on 16 January 2024, at 08:51 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
There is a higher prevalence of spasmodic torticollis in females; females are 1.5 times more likely to develop spasmodic torticollis than males. The prevalence rate of spasmodic torticollis also increases with age, most patients show symptoms from ages 50–69. The average onset age of spasmodic torticollis is 41. [1]